Status:
RECRUITING
Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Adverse Cardiac Event
Major Adverse Cardiac Events
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine hospitalization is developed around the management o...
Detailed Description
The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine is developed around the management of cardiovascular...
Eligibility Criteria
Inclusion
- High-Risk Cardiovascular patients either receiving:
- Primary prevention because they have never had a cardiovascular event but have several cardiovascular risk factors such as high blood pressure particularly resistant, metabolic syndrome, diabetes , dyslipidemia, metabolic steatosis
- Or secondary prevention because they have already had a major cardiovascular event such as ischemic heart disease, heart failure
- Aged 18 and over
- Patient benefiting from comorbidities assessment during their planned hospitalization in the internal medicine department.
Exclusion
- Patient refusal
- Subject not registered in social security system
- Pregnant or breastfeeding woman
- Patient unable to give their informed consent, protected adult, vulnerable people
- Subject deprived of liberty by judicial or administrative decision
Key Trial Info
Start Date :
May 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 21 2027
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06204549
Start Date
May 21 2024
End Date
November 21 2027
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Montpellier, France